Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoidsM. Caplin, Zeng Zheng-Pei, Aurel Perren et al.|Annals of Oncology|2015Cited by 698
Neuroendocrine bronchial and thymic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upKjell Öberg, Mauro Papotti, Per Hellman et al.|Annals of Oncology|2012Cited by 196
Multiple endocrine neoplasia syndrome type 1: institution, management, and data analysis of a nationwide multicenter patient databaseFrancesca Giusti, Maria Luisa Brandi, Luisella Cianferotti et al.|Endocrine|2017Cited by 109
First long-term results on efficacy and safety of long-acting pasireotide in combination with everolimus in patients with advanced carcinoids (NET) of the lung/thymus: Phase II LUNA trial.Éric Baudin, Piero Ferollà, Mario Giuliano et al.|Journal of Clinical Oncology|2021Cited by 7